Osteonic Co. Ltd (226400) — Capital Reinvestment Ratio

Latest as of September 2025: 1.39x

Osteonic Co. Ltd (226400) has a Capital Reinvestment Ratio of 1.39x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩1.09 Billion) in capital expenditures (₩1.52 Billion). Check 226400 tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.39x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.09 Billion
KRW

Capital Expenditures

₩1.52 Billion
KRW

Data as of

Sep 2025
Most recent filing

Osteonic Co. Ltd Capital Reinvestment Ratio (2018–2024)

This chart tracks Osteonic Co. Ltd's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Osteonic Co. Ltd operating cash flow efficiency.

Annual Capital Reinvestment Ratio for Osteonic Co. Ltd (2018–2024)

Year-by-year Capital Reinvestment Ratio for Osteonic Co. Ltd from 2018 to 2024. See Osteonic Co. Ltd (226400) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 1.49x ₩4.72 Billion ₩7.05 Billion ▼ -11.3%
2023 1.68x ₩4.14 Billion ₩6.97 Billion ▲ +1294.5%
2022 0.12x ₩3.99 Billion ₩481.34 Million ▼ -62.1%
2021 0.32x ₩2.95 Billion ₩939.46 Million ▼ -7.5%
2020 0.34x ₩2.75 Billion ₩949.15 Million ▼ -97.9%
2018 16.58x ₩317.53 Million ₩5.26 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow